Schedule 13G/A Filing by The Vanguard Group for Gossamer Bio Inc

This filing is an amendment to a Schedule 13G filed by The Vanguard Group concerning Gossamer Bio Inc. The filing indicates that as of March 27, 2026, The Vanguard Group, including its subsidiaries and managed accounts, holds 0% of Gossamer Bio Inc. stock. The filing clarifies that due to an internal realignment on January 12, 2026, certain subsidiaries of The Vanguard Group, Inc. will now report beneficial ownership separately. The Vanguard Group, Inc. itself no longer holds or is deemed to hold beneficial ownership over securities owned by these subsidiaries. The filing asserts that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing the control of the issuer.